Highlights

[AMVERTON] YoY Quarter Result on 2013-03-31 [#1]

Stock [AMVERTON]: AMVERTON BHD
Announcement Date 29-May-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2013
Quarter 31-Mar-2013  [#1]
Profit Trend QoQ -     -67.12%    YoY -     -26.89%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 25,160 27,758 30,336 26,716 32,507 29,451 33,790 -4.79%
  YoY % -9.36% -8.50% 13.55% -17.81% 10.38% -12.84% -
  Horiz. % 74.46% 82.15% 89.78% 79.06% 96.20% 87.16% 100.00%
PBT 5,685 6,486 6,318 5,044 6,521 5,053 3,710 7.37%
  YoY % -12.35% 2.66% 25.26% -22.65% 29.05% 36.20% -
  Horiz. % 153.23% 174.82% 170.30% 135.96% 175.77% 136.20% 100.00%
Tax -1,488 -1,842 -1,448 -1,395 -1,497 -1,211 -1,223 3.32%
  YoY % 19.22% -27.21% -3.80% 6.81% -23.62% 0.98% -
  Horiz. % 121.67% 150.61% 118.40% 114.06% 122.40% 99.02% 100.00%
NP 4,197 4,644 4,870 3,649 5,024 3,842 2,487 9.10%
  YoY % -9.63% -4.64% 33.46% -27.37% 30.77% 54.48% -
  Horiz. % 168.76% 186.73% 195.82% 146.72% 202.01% 154.48% 100.00%
NP to SH 3,916 4,245 4,427 3,317 4,537 3,286 2,235 9.79%
  YoY % -7.75% -4.11% 33.46% -26.89% 38.07% 47.02% -
  Horiz. % 175.21% 189.93% 198.08% 148.41% 203.00% 147.02% 100.00%
Tax Rate 26.17 % 28.40 % 22.92 % 27.66 % 22.96 % 23.97 % 32.96 % -3.77%
  YoY % -7.85% 23.91% -17.14% 20.47% -4.21% -27.28% -
  Horiz. % 79.40% 86.17% 69.54% 83.92% 69.66% 72.72% 100.00%
Total Cost 20,963 23,114 25,466 23,067 27,483 25,609 31,303 -6.46%
  YoY % -9.31% -9.24% 10.40% -16.07% 7.32% -18.19% -
  Horiz. % 66.97% 73.84% 81.35% 73.69% 87.80% 81.81% 100.00%
Net Worth 602,355 584,102 554,897 518,390 492,836 467,342 450,604 4.95%
  YoY % 3.12% 5.26% 7.04% 5.19% 5.46% 3.71% -
  Horiz. % 133.68% 129.63% 123.14% 115.04% 109.37% 103.71% 100.00%
Dividend
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Net Worth 602,355 584,102 554,897 518,390 492,836 467,342 450,604 4.95%
  YoY % 3.12% 5.26% 7.04% 5.19% 5.46% 3.71% -
  Horiz. % 133.68% 129.63% 123.14% 115.04% 109.37% 103.71% 100.00%
NOSH 365,064 365,064 365,064 365,064 365,064 365,111 360,483 0.21%
  YoY % 0.00% 0.00% 0.00% 0.00% -0.01% 1.28% -
  Horiz. % 101.27% 101.27% 101.27% 101.27% 101.27% 101.28% 100.00%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 16.68 % 16.73 % 16.05 % 13.66 % 15.46 % 13.05 % 7.36 % 14.60%
  YoY % -0.30% 4.24% 17.50% -11.64% 18.47% 77.31% -
  Horiz. % 226.63% 227.31% 218.07% 185.60% 210.05% 177.31% 100.00%
ROE 0.65 % 0.73 % 0.80 % 0.64 % 0.92 % 0.70 % 0.50 % 4.47%
  YoY % -10.96% -8.75% 25.00% -30.43% 31.43% 40.00% -
  Horiz. % 130.00% 146.00% 160.00% 128.00% 184.00% 140.00% 100.00%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 6.89 7.60 8.31 7.32 8.90 8.07 9.37 -4.99%
  YoY % -9.34% -8.54% 13.52% -17.75% 10.29% -13.87% -
  Horiz. % 73.53% 81.11% 88.69% 78.12% 94.98% 86.13% 100.00%
EPS 1.07 1.16 1.21 0.91 1.24 0.90 0.62 9.51%
  YoY % -7.76% -4.13% 32.97% -26.61% 37.78% 45.16% -
  Horiz. % 172.58% 187.10% 195.16% 146.77% 200.00% 145.16% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 1.6500 1.6000 1.5200 1.4200 1.3500 1.2800 1.2500 4.73%
  YoY % 3.12% 5.26% 7.04% 5.19% 5.47% 2.40% -
  Horiz. % 132.00% 128.00% 121.60% 113.60% 108.00% 102.40% 100.00%
Adjusted Per Share Value based on latest NOSH - 365,064
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 6.89 7.60 8.31 7.32 8.90 8.07 9.26 -4.80%
  YoY % -9.34% -8.54% 13.52% -17.75% 10.29% -12.85% -
  Horiz. % 74.41% 82.07% 89.74% 79.05% 96.11% 87.15% 100.00%
EPS 1.07 1.16 1.21 0.91 1.24 0.90 0.61 9.81%
  YoY % -7.76% -4.13% 32.97% -26.61% 37.78% 47.54% -
  Horiz. % 175.41% 190.16% 198.36% 149.18% 203.28% 147.54% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 1.6500 1.6000 1.5200 1.4200 1.3500 1.2802 1.2343 4.95%
  YoY % 3.12% 5.26% 7.04% 5.19% 5.45% 3.72% -
  Horiz. % 133.68% 129.63% 123.15% 115.04% 109.37% 103.72% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 -
Price 0.8200 1.1100 1.2200 0.5950 0.4500 0.4900 0.7000 -
P/RPS 11.90 14.60 14.68 8.13 5.05 6.07 7.47 8.06%
  YoY % -18.49% -0.54% 80.57% 60.99% -16.80% -18.74% -
  Horiz. % 159.30% 195.45% 196.52% 108.84% 67.60% 81.26% 100.00%
P/EPS 76.44 95.46 100.60 65.48 36.21 54.44 112.90 -6.29%
  YoY % -19.92% -5.11% 53.63% 80.83% -33.49% -51.78% -
  Horiz. % 67.71% 84.55% 89.11% 58.00% 32.07% 48.22% 100.00%
EY 1.31 1.05 0.99 1.53 2.76 1.84 0.89 6.65%
  YoY % 24.76% 6.06% -35.29% -44.57% 50.00% 106.74% -
  Horiz. % 147.19% 117.98% 111.24% 171.91% 310.11% 206.74% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.50 0.69 0.80 0.42 0.33 0.38 0.56 -1.87%
  YoY % -27.54% -13.75% 90.48% 27.27% -13.16% -32.14% -
  Horiz. % 89.29% 123.21% 142.86% 75.00% 58.93% 67.86% 100.00%
Price Multiplier on Announcement Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 26/05/16 29/05/15 29/05/14 29/05/13 30/05/12 27/05/11 25/05/10 -
Price 1.1800 0.9300 1.3100 0.7800 0.4400 0.4800 0.5900 -
P/RPS 17.12 12.23 15.76 10.66 4.94 5.95 6.29 18.14%
  YoY % 39.98% -22.40% 47.84% 115.79% -16.97% -5.41% -
  Horiz. % 272.18% 194.44% 250.56% 169.48% 78.54% 94.59% 100.00%
P/EPS 110.00 79.98 108.03 85.85 35.40 53.33 95.16 2.44%
  YoY % 37.53% -25.97% 25.84% 142.51% -33.62% -43.96% -
  Horiz. % 115.59% 84.05% 113.52% 90.22% 37.20% 56.04% 100.00%
EY 0.91 1.25 0.93 1.16 2.82 1.88 1.05 -2.35%
  YoY % -27.20% 34.41% -19.83% -58.87% 50.00% 79.05% -
  Horiz. % 86.67% 119.05% 88.57% 110.48% 268.57% 179.05% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.72 0.58 0.86 0.55 0.33 0.38 0.47 7.36%
  YoY % 24.14% -32.56% 56.36% 66.67% -13.16% -19.15% -
  Horiz. % 153.19% 123.40% 182.98% 117.02% 70.21% 80.85% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS